What investors should track next: three questions HIMS must answer Going forward, HIMS needs to prove that: It can scale weight management in a compliant way It can maintain gross margin and growth under tighter regulation After GLP1-driven volatility fades, its subscription base can still compound over time Five metrics to watch in coming quarters Net subscriber adds + ARPU (average revenue per user): the hard indicators of quantity and quality of platform growth
The tirzepatide dose chart shows a standard titration from 2.5 mg up to 15 mg, and interestingly, the hair loss rate did not increase meaningfully between the 5 mg and 15 mg groups
The idea of simultaneously activating both the GIP and GLP-1 receptors seems appealing for treatment of T2DM since it may significantly boost insulin secretion and improve insulin sensitivity
Yes, it is recommended to take one capsule twice daily or as recommended by the doctor
Answer 6 questions and see typical peptides, dosing, injection schedule, reconstitution steps, cycle length, and when patients pause
S., Viegas, R
